UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
Date: October 28, 2016
UBS Group AG
Commission File Number: 1-36764
UBS AG
Commission File Number: 1-15060
(Registrants' Names)
Bahnhofstrasse 45, Zurich, Switzerland, and
Aeschenvorstadt 1, Basel, Switzerland
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20‑F or Form 40-F.
Form 20-F x Form 40-F o
This Form 6-K consists of the following legal entity financial information for the third quarter of 2016, which appears immediately following this page:
1. UBS Group AG (standalone) selected financial information
2. UBS Switzerland AG (standalone) financial and regulatory information
3. UBS Limited (standalone) financial and regulatory information
4. UBS Americas Holding LLC (consolidated) selected financial information
UBS Group AG (standalone)
selected financial information
Third quarter 2016
Selected financial information¹ |
|
|
|
|
|
|
|
|
|
|
|
For the quarter ended |
|
Year-to-date |
|||||
CHF million |
|
30.9.16 |
30.6.16 |
31.12.15 |
30.9.15 |
|
30.9.16 |
30.9.15 |
|
|
|
|
|
|
|
|
|
|
|
Income statement |
|
|
|
|
|
|
|
|
|
Operating income |
|
140 |
3,565 |
121 |
1,111 |
|
3,833 |
3,123 |
|
of which: dividend income from the investment in UBS AG |
|
|
3,434 |
|
1,000 |
|
3,434 |
2,869 |
|
of which: other operating income |
|
140 |
131 |
121 |
111 |
|
399 |
254 |
|
Operating expenses |
|
152 |
144 |
118 |
114 |
|
444 |
361 |
|
Operating profit / (loss) before tax |
|
(12) |
3,421 |
3 |
997 |
|
3,389 |
2,762 |
|
Tax expense / (benefit) |
|
7 |
6 |
7 |
2 |
|
18 |
2 |
|
Net profit / (loss) |
|
(20) |
3,415 |
(3) |
995 |
|
3,371 |
2,759 |
|
|
|
|
|
|
|
||||
|
|
|
As of |
||||||
CHF million |
|
|
30.9.16 |
30.6.16 |
31.12.15 |
||||
|
|
|
|
|
|
||||
Balance sheet |
|
|
|
|
|
||||
Total assets |
|
|
50,846 |
49,557 |
48,381 |
||||
of which: investment in UBS AG |
|
|
40,376 |
40,376 |
40,376 |
||||
of which: long-term receivables due from UBS AG² |
|
|
7,573 |
6,533 |
5,171 |
||||
Total liabilities |
|
|
12,796 |
11,525 |
9,966 |
||||
of which: additional tier 1 capital³ |
|
|
7,573 |
6,533 |
5,106 |
||||
Equity attributable to shareholders |
|
|
38,049 |
38,031 |
38,415 |
||||
1 The UBS Group AG standalone selected financial information is prepared in accordance with the principles of the Swiss Law on Accounting and Financial Reporting (32nd title of the Swiss Code of Obligations), but does not represent interim financial statements. More information on the accounting policies applied for the standalone financial statements of UBS Group AG is provided in Note 2 to the UBS Group AG standalone financial statements in the Annual Report 2015. 2 Long-term receivables due from UBS AG comprise the onward lending of the proceeds from the issuances of additional tier 1 (AT1) perpetual capital notes. 3 Comprised of long-term interest-bearing liabilities, which qualify as AT1 capital on UBS Group AG consolidated level. Compensation-related liabilities for Deferred Contingent Capital Plan (DCCP) awards granted for the performance years 2014 and 2015, which also qualify as AT1 capital, are not included. |
|||||||||
Notice to investors | This document and the information contained herein are provided solely for information purposes, and are not to be construed as solicitation of an offer to buy or sell any securities or other financial instruments in Switzerland, the United States or any other jurisdiction. No investment decision relating to securities of or relating to UBS Group AG, UBS AG or their affiliates should be made on the basis of this document. Refer to UBS’s third quarter 2016 report and its Annual Report 2015 for additional information. These reports are available at www.ubs.com/investors.
Rounding | Numbers presented throughout this document may not add up precisely to the totals provided in the tables and text. Percentages, percent changes and absolute variances are calculated on the basis of rounded figures displayed in the tables and text and may not precisely reflect the percentages, percent changes and absolute variances that would be derived based on figures that are not rounded.
Tables | Within tables, blank fields generally indicate that the field is not applicable or not meaningful, or that information is not available as of the relevant date or for the relevant period. Zero values generally indicate that the respective figure is zero on an actual or rounded basis. Percentage changes are presented as a mathematical calculation of the change between periods.
1
UBS Switzerland AG (standalone)
financial and regulatory information
Third quarter 2016
This document contains selected financial information as well as information related to capital adequacy, the leverage ratio and the liquidity coverage ratio, as required by the FINMA Circular 2008 / 22 “Disclosure – banks.” It also contains the overview of UBS Switzerland AG’s capital instrument key features as of 30 September 2016.
1
Selected financial information |
|
|
||||||||
|
|
For the quarter ended |
|
Year-to-date |
||||||
CHF million |
|
|
|
30.9.16 |
30.6.16 |
31.12.15 |
30.9.15 |
|
30.9.16 |
30.9.15¹ |
|
|
|
|
|
|
|
|
|
|
|
Income statement² |
|
|
|
|
|
|
|
|
|
|
Net interest income (including credit loss expense / recovery) |
|
|
|
869 |
876 |
819 |
837 |
|
2,617 |
1,662 |
Net fee and commission income |
|
|
|
954 |
951 |
968 |
1,004 |
|
2,861 |
2,033 |
Net trading income |
|
|
|
231 |
175 |
264 |
224 |
|
561 |
471 |
Other income from ordinary activities |
|
|
|
31 |
198 |
12 |
(5) |
|
298 |
67 |
Total operating income |
|
|
|
2,085 |
2,199 |
2,063 |
2,060 |
|
6,338 |
4,232 |
Personnel expenses |
|
|
|
529 |
528 |
525 |
534 |
|
1,596 |
1,083 |
General and administrative expenses |
|
|
|
883 |
845 |
925 |
874 |
|
2,589 |
1,658 |
Amortization and impairment of goodwill and other intangible assets |
|
|
|
263 |
263 |
263 |
263 |
|
788 |
525 |
Other operating expenses |
|
|
|
(1) |
2 |
6 |
10 |
|
6 |
20 |
Total operating expenses |
|
|
|
1,673 |
1,637 |
1,719 |
1,680 |
|
4,978 |
3,286 |
Operating profit |
|
|
|
412 |
562 |
344 |
380 |
|
1,359 |
946 |
Tax expense / (benefit) |
|
|
|
96 |
122 |
81 |
87 |
|
308 |
141 |
Net profit / (loss) |
|
|
|
316 |
440 |
263 |
293 |
|
1,051 |
805 |
|
|
|||||
|
|
As of |
||||
CHF million |
|
|
|
30.9.16 |
30.6.16 |
31.12.15 |
|
|
|
|
|
|
|
Balance sheet² |
|
|
|
|
|
|
Cash and balances with central banks |
|
|
|
50,304 |
46,418 |
38,701 |
Due from banks |
|
|
|
7,552 |
4,377 |
3,477 |
Receivables from securities financing transactions |
|
|
|
28,498 |
31,251 |
23,672 |
Due from customers |
|
|
|
37,918 |
37,931 |
38,373 |
Mortgage loans |
|
|
|
147,055 |
147,252 |
148,492 |
Financial investments |
|
|
|
22,294 |
22,707 |
22,878 |
Goodwill and other intangible assets |
|
|
|
3,675 |
3,938 |
4,463 |
Other assets |
|
|
|
5,628 |
6,238 |
5,122 |
Total assets |
|
|
|
302,924 |
300,111 |
285,176 |
Due to banks |
|
|
|
17,174 |
17,772 |
19,280 |
Payables from securities financing transactions |
|
|
|
10,580 |
12,116 |
8,997 |
Due to customers |
|
|
|
247,886 |
242,396 |
231,294 |
Bonds issued and loans from central mortgage institutions |
|
|
|
8,177 |
8,144 |
8,274 |
Other liabilities |
|
|
|
3,906 |
4,799 |
3,183 |
Total liabilities |
|
|
|
287,724 |
285,227 |
271,027 |
Total equity |
|
|
|
15,200 |
14,884 |
14,149 |
1 Primarily represents income and expenses for the second and third quarter of 2015. During the first quarter of 2015, UBS Switzerland AG had no operations and therefore recorded virtually no profit or loss during that period. 2 The UBS Switzerland AG standalone selected financial information is prepared in accordance with Swiss GAAP (FINMA Circular 2015 / 1 and the Banking Ordinance), but does not represent interim financial statements under Swiss GAAP. Refer to Note 2 to the UBS Switzerland AG standalone financial statements in the Annual Report 2015 for more information. |
In June 2015, the Personal & Corporate Banking and Wealth Management businesses booked in Switzerland were transferred from UBS AG to UBS Switzerland AG through an asset transfer in accordance with the Swiss Merger Act. Under the Swiss Merger Act, UBS AG assumed joint liability for obligations existing on the asset transfer date, 14 June 2015, which were transferred to UBS Switzerland AG. Under the terms of the asset transfer agreement, UBS Switzerland AG assumed joint liability for approximately CHF 325 billion of contractual obligations of UBS AG existing on the asset transfer date, excluding the collateralized portion of secured contractual obligations and covered bonds. UBS Switzerland AG has no liability for new obligations incurred by UBS AG after the asset transfer date. Under certain circumstances, the Swiss Banking Act and the bank insolvency ordinance of the Swiss Financial Market Supervisory Authority (FINMA) authorize FINMA to modify, extinguish or convert to common equity liabilities of a bank in connection with a resolution or insolvency of such bank.
® Refer to “Establishment of UBS Switzerland AG” in the “Legal entity financial and regulatory information” section of our Annual Report 2015 for more information
The joint liability amount declines as obligations mature, terminate or are novated following the asset transfer date. As of 30 September 2016, the joint liability of UBS Switzerland AG amounted to approximately CHF 95 billion.
3
Swiss SRB going and gone concern requirements and information
UBS Switzerland AG is considered a systemically relevant bank (SRB) under Swiss banking law and is subject to capital regulations on a standalone basis. In May 2016, the Swiss Federal Council adopted amendments to the too big to fail (TBTF) provisions, based on the cornerstones announced by the Swiss Federal Council in October 2015. The revised Capital Adequacy Ordinance forms the basis of a revised Swiss SRB framework, which became effective on 1 July 2016.
As of 30 September 2016, the going concern capital and leverage ratio requirements for UBS Switzerland AG (standalone) were 11.19% and 3.0%, respectively. The gone concern requirements on a phase-in basis were 3.5% for the RWA-based requirement and 1.0% for the LRD-based requirement.
® Refer to the “Capital management” section of the UBS Group third quarter 2016 report for more information on the revised Swiss SRB framework.
Swiss SRB going and gone concern requirements and information¹ |
||||||||||
|
|
Swiss SRB including transitional arrangements (phase-in) |
||||||||
As of 30.9.16 |
|
Risk-weighted assets |
|
Leverage ratio denominator |
||||||
CHF million, except where indicated |
|
Requirement (%)² |
Actual (%) |
Requirement |
Eligible |
|
Requirement (%) |
Actual (%) |
Requirement |
Eligible |
Common equity tier 1 capital |
|
8.57 |
11.27 |
7,962 |
10,476 |
|
2.30 |
3.33 |
7,246 |
10,476 |
Maximum high-trigger loss-absorbing additional tier 1 capital |
|
2.63 |
1.34 |
2,439 |
1,247 |
|
0.70 |
0.40 |
2,205 |
1,247 |
of which: high-trigger loss-absorbing additional tier 1 capital |
|
|
1.34 |
|
1,247 |
|
|
0.40 |
|
1,247 |
Total going concern |
|
11.19³ |
12.62 |
10,401 |
11,724 |
|
3.00⁴ |
3.72 |
9,452 |
11,724 |
Base gone concern requirement |
|
3.50 |
3.50 |
3,253 |
3,253 |
|
1.00 |
1.03 |
3,151 |
3,253 |
of which: high-trigger loss-absorbing additional tier 1 capital |
|
|
0.81 |
|
753 |
|
|
0.24 |
|
753 |
of which: low-trigger loss-absorbing tier 2 capital |
|
|
2.69 |
|
2,500 |
|
|
0.79 |
|
2,500 |
Total gone concern |
|
3.50 |
3.50 |
3,253 |
3,253 |
|
1.00 |
1.03 |
3,151 |
3,253 |
Total loss-absorbing capacity |
|
14.69 |
16.12 |
13,653 |
14,976 |
|
4.00 |
4.75 |
12,602 |
14,976 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Swiss SRB as of 1.1.20 (fully applied) |
||||||||
As of 30.9.16 |
|
Risk-weighted assets |
|
Leverage ratio denominator |
||||||
CHF million, except where indicated |
|
Requirement (%) |
Actual (%) |
Requirement |
Eligible |
|
Requirement (%) |
Actual (%) |
Requirement |
Eligible |
Common equity tier 1 capital |
|
10.44 |
11.20 |
9,704 |
10,405 |
|
3.50 |
3.30 |
11,024 |
10,405 |
Maximum high-trigger loss-absorbing additional tier 1 capital |
|
4.30 |
2.15 |
3,996 |
2,000 |
|
1.50 |
0.63 |
4,725 |
2,000 |
of which: high-trigger loss-absorbing additional tier 1 capital |
|
|
2.15 |
|
2,000 |
|
|
0.63 |
|
2,000 |
Total going concern |
|
14.74⁵ |
13.35 |
13,700 |
12,405 |
|
5.00⁶ |
3.94 |
15,749 |
12,405 |
Base gone concern requirement including applicable add-ons |
|
14.30 |
2.69 |
13,289 |
2,500 |
|
5.00 |
0.79 |
15,749 |
2,500 |
of which: low-trigger loss-absorbing tier 2 capital |
|
|
2.69 |
|
2,500 |
|
|
0.79 |
|
2,500 |
Total gone concern |
|
14.30 |
2.69 |
13,289 |
2,500 |
|
5.00 |
0.79 |
15,749 |
2,500 |
Total loss-absorbing capacity |
|
29.04 |
16.04 |
26,989 |
14,905 |
|
10.00 |
4.73 |
31,498 |
14,905 |
1 This table does not include the effect of any potential rebate. 2 The total capital ratio requirement of 14.69% is the current phase-in requirement according to the Swiss Capital Adequacy Ordinance. In addition, FINMA has defined a total capital ratio requirement, which is the sum of 14.4% and the effect of countercyclical buffer requirements of 0.44%, of which 10% plus the effect of countercyclical buffer requirements must be satisfied with common equity tier 1 capital. The FINMA total capital requirement will be effective until it is exceeded by the Swiss SRB phase-in requirement. 3 Consists of a minimum capital requirement of 8% and a buffer capital requirement of 3.19%, including the effect of countercyclical buffers of 0.44%. 4 Consists of a minimum leverage ratio requirement of 3%. 5 Consists of a minimum capital requirement of 8% and a buffer capital requirement of 6.74%, including the effect of countercyclical buffers of 0.44% and applicable add-ons of 1.44%. 6 Consists of a minimum leverage ratio requirement of 3% and a buffer leverage ratio requirement of 2%, including applicable add-ons of 0.5%. |
4
Swiss SRB loss-absorbing capacity
As of 30 September 2016, our total loss-absorbing capacity ratio was 16.0% on a fully applied basis and 16.1% on a phase-in basis.
® Refer to the document “UBS Switzerland AG (standalone) regulatory information – 30 June 2016” under “Disclosures for subsidiaries and branches” at www.ubs.com/investors for prior-period information.
Swiss SRB going and gone concern information |
|
|||
As of 30.9.16 |
|
Swiss SRB including transitional arrangements (phase-in) |
|
Swiss SRB as of 1.1.20 (fully applied) |
CHF million, except where indicated |
|
|
|
|
|
|
|
|
|
Going concern capital |
|
|
|
|
Common equity tier 1 capital |
|
10,476 |
|
10,405 |
High-trigger loss-absorbing additional tier 1 capital |
|
1,247¹ |
|
2,000 |
Total going concern capital |
|
11,724 |
|
12,405 |
|
|
|
|
|
Gone concern loss-absorbing capacity |
|
|
|
|
High-trigger loss-absorbing additional tier 1 capital |
|
753¹ |
|
|
Low-trigger loss-absorbing tier 2 capital |
|
2,500¹ |
|
2,500 |
Total gone concern loss-absorbing capacity |
|
3,253 |
|
2,500 |
|
|
|
|
|
Total loss-absorbing capacity |
|
|
|
|
Total loss-absorbing capacity |
|
14,976 |
|
14,905 |
|
|
|
|
|
Risk-weighted assets / leverage ratio denominator |
|
|
|
|
Risk-weighted assets |
|
92,929 |
|
92,929 |
Leverage ratio denominator |
|
315,057 |
|
314,985 |
|
|
|
|
|
Capital and loss-absorbing capacity ratios (%) |
|
|
|
|
Going concern capital ratio |
|
12.6 |
|
13.3 |
of which: common equity tier 1 capital ratio |
|
11.3 |
|
11.2 |
Gone concern loss-absorbing capacity ratio |
|
3.5 |
|
2.7 |
Total loss-absorbing capacity ratio |
|
16.1 |
|
16.0 |
|
|
|
|
|
Leverage ratios (%) |
|
|
|
|
Going concern leverage ratio |
|
3.7 |
|
3.9 |
of which: common equity tier 1 leverage ratio |
|
3.3 |
|
3.3 |
Gone concern leverage ratio |
|
1.0 |
|
0.8 |
Total loss-absorbing capacity leverage ratio |
|
4.8 |
|
4.7 |
1 Under the Swiss SRB rules, going concern capital includes CET1 and high-trigger additional tier 1 capital. Outstanding low-trigger tier 2 capital instruments will also remain available to meet the going concern capital requirements until the earlier of their maturity or first call date or 31 December 2019. However, as of 30 September 2016, CHF 753 million of high-trigger loss-absorbing additional tier 1 capital as well as the total low-trigger loss-absorbing tier 2 capital of CHF 2,500 million were used to meet the gone concern requirement. |
5
Leverage ratio information
As of 30 September 2016, our total loss-absorbing capacity leverage ratio was 4.7% on a fully applied basis and 4.8% on a phase-in basis.
® Refer to the document “UBS Switzerland AG (standalone) regulatory information – 30 June 2016” under “Disclosures for subsidiaries and branches” at www.ubs.com/investors for prior-period information.
Swiss SRB leverage ratio |
|
|
|
|
As of 30.9.16 |
|
Swiss SRB including transitional arrangements (phase-in) |
|
Swiss SRB as of 1.1.20 (fully applied) |
|
|
|
|
|
Leverage ratio denominator (CHF billion) |
|
|
|
|
Swiss GAAP total assets |
|
302.9 |
|
302.9 |
Difference between Swiss GAAP and IFRS total assets |
|
2.4 |
|
2.4 |
Less derivative exposures and SFTs¹ |
|
(35.7) |
|
(35.7) |
On-balance sheet exposures (excluding derivative exposures and SFTs) |
|
269.7 |
|
269.7 |
Derivative exposures |
|
5.2 |
|
5.2 |
Securities financing transactions |
|
29.2 |
|
29.2 |
Off-balance sheet items |
|
11.3 |
|
11.3 |
Items deducted from Swiss SRB tier 1 capital |
|
(0.4) |
|
(0.4) |
Total exposures (leverage ratio denominator) |
|
315.1 |
|
315.0 |
|
|
|
|
|
Loss-absorbing capacity (CHF million) |
|
|
|
|
Going concern capital |
|
11,724² |
|
12,405 |
of which: common equity tier 1 capital |
|
10,476 |
|
10,405 |
Gone concern loss-absorbing capacity |
|
3,253² |
|
2,500 |
Total loss-absorbing capacity |
|
14,976 |
|
14,905 |
|
|
|
|
|
Leverage ratios (%) |
|
|
|
|
Going concern leverage ratio |
|
3.7 |
|
3.9 |
of which: common equity tier 1 leverage ratio |
|
3.3 |
|
3.3 |
Gone concern leverage ratio |
|
1.0 |
|
0.8 |
Total loss-absorbing capacity leverage ratio |
|
4.8 |
|
4.7 |
1 Consists of positive replacement values, cash collateral receivables on derivative instruments, cash collateral on securities borrowed, reverse repurchase agreements, margin loans and prime brokerage receivables related to securities financing transactions, which are presented separately under Derivative exposures and Securities financing transactions in this table. 2 Under the Swiss SRB rules, going concern capital includes CET1 and high-trigger additional tier 1 capital. Outstanding low-trigger tier 2 capital instruments will also remain available to meet the going concern capital requirements until the earlier of their maturity or first call date or 31 December 2019. However, as of 30 September 2016, CHF 753 million of high-trigger loss-absorbing additional tier 1 capital as well as the total low-trigger loss-absorbing tier 2 capital of CHF 2,500 million were used to meet the gone concern requirement. |
6
BIS Basel III leverage ratio
On 1 January 2015, disclosure requirements for the leverage ratio in accordance with BIS Basel III regulations came into effect in Switzerland, and UBS Switzerland AG is required to disclose BIS Basel III leverage ratio information on a quarterly basis.
The table below provides BIS Basel III leverage ratio information for UBS Switzerland AG as of 30 September 2016 according to the current disclosure requirements.
BIS Basel III leverage ratio (phase-in) |
|
|
|
|
CHF million, except where indicated |
30.9.16 |
30.6.16 |
31.3.16 |
31.12.15 |
Total tier 1 capital |
12,476 |
12,489 |
12,495 |
11,968 |
Total exposures (leverage ratio denominator) |
315,057 |
313,285 |
309,001 |
296,865 |
BIS Basel III leverage ratio (%) |
4.0 |
4.0 |
4.0 |
4.0 |
Liquidity coverage ratio
BIS Basel III rules require disclosure of the liquidity coverage ratio (LCR). As a Swiss SRB, UBS Switzerland AG must maintain an LCR of at least 100% and disclose LCR information on a quarterly basis.
Liquidity coverage ratio |
|
|
|
|
|
|
Weighted value¹ |
||
CHF billion, except where indicated |
|
Average 3Q16 |
Average 2Q16 |
Average 4Q15 |
High-quality liquid assets |
|
82 |
81 |
75 |
Total net cash outflows |
|
72 |
72 |
65 |
of which: cash outflows |
|
106 |
105 |
106 |
of which: cash inflows |
|
34 |
33 |
41 |
Liquidity coverage ratio (%) |
|
114 |
113 |
115 |
1 Calculated after the application of haircuts and inflow and outflow rates. |
7
Capital instruments of UBS Switzerland AG - Key features |
|||||||||
Presented according to issuance date |
|||||||||
|
|
|
Share capital |
|
Additional Tier 1 capital |
|
Tier 2 capital |
|
Additional Tier 1 capital |
1 |
Issuer (country of incorporation; if applicable, branch) |
|
UBS Switzerland AG, Switzerland |
|
UBS Switzerland AG, Switzerland |
|
UBS Switzerland AG, Switzerland |
|
UBS Switzerland AG, Switzerland |
1a |
Instrument number |
|
1 |
|
2 |
|
3 |
|
4 |
2 |
Unique identifier (e.g., ISIN) |
|
N/A |
|
N/A |
|
N/A |
|
N/A |
3 |
Governing law(s) of the instrument |
|
Swiss |
|
Swiss |
|
Swiss |
|
Swiss |
|
Regulatory treatment |
|
|
|
|
|
|
|
|
4 |
Transitional Basel III rules (1) |
|
Common Equity Tier 1 – Going concern capital |
|
Additional Tier 1 – Going concern capital |
|
Tier 2 – Going concern capital (4) |
|
Additional Tier 1 – Going concern capital |
5 |
Post-transitional Basel III rules (2) |
|
Common Equity Tier 1 – Going concern capital |
|
Additional Tier 1 – Going concern capital |
|
Tier 2 – Gone concern loss-absorbing capacity (4) |
|
Additional Tier 1 – Going concern capital |
6 |
Eligible at solo/group/group&solo |
|
UBS Switzerland AG standalone |
|
UBS Switzerland AG standalone |
|
UBS Switzerland AG standalone |
|
UBS Switzerland AG standalone |
7 |
Instrument type |
|
Ordinary shares |
|
Loan (5) |
|
Loan (5) |
|
Loan (5) |
8 |
Amount recognized in regulatory capital (Currency in million, as of most recent reporting date) (1) |
|
CHF 10.0 |
|
CHF 1,500 |
|
CHF 2,500 |
|
CHF 500 |
9 |
Outstanding amount (par value, million) |
|
CHF 10.0 |
|
CHF 1,500 |
|
CHF 2,500 |
|
CHF 500 |
10 |
Accounting classification (3) |
|
Equity attributable to UBS Switzerland AG shareholders |
|
Due to banks held at amortized cost |
|
Due to banks held at amortized cost |
|
Due to banks held at amortized cost |
11 |
Original date of issuance |
|
– |
|
1 April 2015 |
|
1 April 2015 |
|
11 March 2016 |
12 |
Perpetual or dated |
|
– |
|
Perpetual |
|
Dated |
|
Perpetual |
13 |
Original maturity date |
|
– |
|
– |
|
1 April 2025 |
|
– |
14 |
Issuer call subject to prior supervisory approval |
|
– |
|
Yes |
|
Yes |
|
Yes |
15 |
Optional call date, subsequent call dates, if applicable, and redemption amount |
|
– |
|
First optional repayment date: 1 April 2020 |
|
First optional repayment date: 1 April 2020 |
|
First optional repayment date: 11 March 2021 |
|
Repayable at any time after the first optional repayment date Repayment subject to FINMA's approval. Optional repayment amount: principal amount, together with any accrued and unpaid interest thereon |
||||||||
16 |
Contingent call dates and redemption amount |
|
– |
|
Early repayment possible due to a tax or regulatory event. Repayment due to tax event subject to FINMA approval. Repayment amount: principal amount, together with accrued and unpaid interest |
||||
|
|
– |
|
Early repayment possible upon a change in progressive capital component requirement, subject to FINMA's approval. Repayment amount: 101% of principal amount, together with accrued and unpaid interest |
|
– |
|||
|
Coupons / dividend |
|
|
|
|
|
|
|
|
17 |
Fixed or floating dividend / coupon |
|
– |
|
Floating |
|
Floating |
|
Floating |
18 |
Coupon rate and any related index; frequency of payment |
|
– |
|
6-month CHF Libor + 370 bp per annum semi-annually |
|
6-month CHF Libor + 200 bp per annum semi-annually |
|
3-month CHF Libor + 459 bp per annum quarterly |
19 |
Existence of a dividend stopper |
|
– |
|
No |
|
No |
|
No |
20 |
Fully discretionary, partially discretionary, or mandatory |
|
Fully discretionary |
|
Fully discretionary |
|
Mandatory |
|
Fully discretionary |
21 |
Existence of step-up or other incentive to redeem |
|
– |
|
No |
|
No |
|
No |
8
Capital instruments of UBS Switzerland AG - Key features (continued) |
|||||||||
22 |
Non-cumulative or cumulative |
|
Non-cumulative |
|
Non-cumulative |
|
Cumulative |
|
Non-cumulative |
23 |
Convertible or non-convertible |
|
– |
|
Non-convertible |
|
Non-convertible |
|
Non-convertible |
24 |
If convertible, conversion trigger(s) |
|
– |
|
– |
|
– |
|
– |
25 |
If convertible, fully or partially |
|
– |
|
– |
|
– |
|
– |
26 |
If convertible, conversion rate |
|
– |
|
– |
|
– |
|
– |
27 |
If convertible, mandatory or optional conversion |
|
– |
|
– |
|
– |
|
– |
28 |
If convertible, specify instrument type convertible into |
|
– |
|
– |
|
– |
|
– |
29 |
If convertible, specify issuer of instrument it converts into |
|
– |
|
– |
|
– |
|
– |
30 |
Write-down feature |
|
– |
|
Yes |
|
Yes |
|
Yes |
31 |
If write-down, write-down trigger(s) |
|
– |
|
– Trigger CET1 Ratio is less than 7% |
|
– Trigger CET1 Ratio is less than 5% |
|
– Trigger CET1 Ratio is less than 7% |
|
|
– FINMA determines a write-down necessary to ensure UBS Switzerland AG's viability; or UBS Switzerland AG receives a commitment of governmental support that FINMA determines necessary to ensure UBS Switzerland AG's viability Subject to applicable conditions. |
|||||||
32 |
If write-down, full or partial |
|
– |
|
Full |
|
Full |
|
Full |
33 |
If write-down, permanent or temporary |
|
– |
|
Permanent |
|
Permanent |
|
Permanent |
34 |
If temporary write-down, description of write-up mechanism |
|
– |
|
– |
|
– |
|
– |
35 |
Position in subordination hierarchy in liquidation (specify instrument type immediately senior to instrument) |
|
Unless otherwise stated in the articles of association, once debts are paid back, the assets of the liquidated company are divided between the shareholders pro rata based on their contributions and considering the preferences attached to certain categories of shares (section 745, Swiss Civil Code of Obligations) |
|
Subject to any obligations that are mandatorily preferred by law, all obligations of UBS Switzerland AG that are unsubordinated, or that are subordinated and do not rank junior, such as all classes of share capital, or at par, such as tier 1 instruments |
|
Subject to any obligations that are mandatorily preferred by law, all obligations of UBS Switzerland AG that are unsubordinated, or that are subordinated and do not rank junior, such as all classes of share capital, or at par, such as unsecured, subordinated and dated obligations |
|
Subject to any obligations that are mandatorily preferred by law, all obligations of UBS Switzerland AG that are unsubordinated, or that are subordinated and do not rank junior, such as all classes of share capital, or at par, such as tier 1 instruments |
36 |
Existence of features, which prevent full recognition under Basel III |
|
– |
|
– |
|
– |
|
– |
37 |
If yes, specify non-compliant features |
|
– |
|
– |
|
– |
|
– |
(1) Based on Swiss SRB phase-in (including transitional arrangement) requirements. (2) Based on Swiss SRB requirements applicable as of 1.1.20. (3) As applied in UBS Switzerland AG's financial statements under Swiss GAAP. (4) Outstanding low-trigger loss-absorbing tier 2 capital qualifies as going concern capital until the earlier of maturity or first call date and 31 December 2019. Afterwards, it qualifies to meet gone concern requirements until one year before maturity, with a haircut of 50% applied in the last year of eligibility. (5) Loans granted by UBS AG, Switzerland. |
9
Notice to investors | This document and the information contained herein are provided solely for information purposes, and are not to be construed as solicitation of an offer to buy or sell any securities or other financial instruments in Switzerland, the United States or any other jurisdiction. No investment decision relating to securities of or relating to UBS Group AG, UBS AG or their affiliates should be made on the basis of this document. Refer to UBS’s third quarter 2016 report and its Annual Report 2015 for additional information. These reports are available at www.ubs.com/investors.
Rounding | Numbers presented throughout this document may not add up precisely to the totals provided in the tables and text. Percentages, percent changes and absolute variances are calculated on the basis of rounded figures displayed in the tables and text and may not precisely reflect the percentages, percent changes and absolute variances that would be derived based on figures that are not rounded.
Tables | Within tables, blank fields generally indicate that the field is not applicable or not meaningful, or that information is not available as of the relevant date or for the relevant period. Zero values generally indicate that the respective figure is zero on an actual or rounded basis. Percentage changes are presented as a mathematical calculation of the change between periods.
10
UBS Limited (standalone)
financial and regulatory information
Third quarter 2016
This document contains selected financial information as well as certain Pillar 3 disclosures as of 30 September 2016 of UBS Limited. The required Pillar 3 disclosures are prepared in accordance with the European Banking Authority (EBA) guidelines and are based upon the EU regulations, Directive 2013/36/EU and Regulation 575/2013 (together known as "CRD IV") and their related technical standards, as implemented within the UK by the Prudential Regulation Authority (PRA). Information provided in this document has not been audited by the external auditors of UBS Limited.
1
Table of contents
3 |
|
|
|
4 |
|
4 |
|
4 |
|
5 |
|
5 |
|
|
|
2
Corporate information and selected financial information
UBS Limited is a credit institution incorporated in Great Britain which is authorised by the PRA and regulated by the Financial Conduct Authority (FCA) and the PRA.
UBS Limited is a wholly owned subsidiary of UBS AG, which is a wholly owned subsidiary of UBS Group AG. Qualitative disclosures around risk management policies and processes of UBS are provided in the "Risk management" section of UBS Group AG's Annual Report 2015, available under "Annual Reporting" at www.ubs.com/investors.
Selected financial information |
|
|
|
|
|
|
|
|
|
|
|
As of or for the quarter ended |
|
As of or year-to-date |
|||||
GBP million |
|
30.9.16 |
30.6.16 |
31.12.15 |
30.9.15 |
|
30.9.16 |
30.9.15 |
|
|
|
|
|
|
|
|
|
|
|
Income statement¹ |
|
|
|
|
|
|
|
|
|
Net interest income (including credit loss expense / recovery) |
|
16 |
(7) |
(4) |
15 |
|
9 |
2 |
|
Net fee and commission income |
|
181 |
221 |
208 |
167 |
|
593 |
606 |
|
Net trading income |
|
8 |
32 |
9 |
17 |
|
40 |
9 |
|
Other income |
|
(52) |
(29) |
(7) |
(31) |
|
(102) |
(96) |
|
Total operating income |
|
153 |
217 |
206 |
168 |
|
540 |
521 |
|
Total operating expenses |
|
142 |
147 |
142 |
111 |
|
426 |
396 |
|
Operating profit before tax |
|
11 |
70 |
64 |
57 |
|
114 |
125 |
|
Tax expense / (benefit) |
|
76 |
13 |
(29) |
(44) |
|
94 |
(23) |
|
Net profit / (loss) |
|
(66) |
58 |
93 |
101 |
|
20 |
148 |
|
Total other comprehensive income |
|
0 |
(2) |
(6) |
3 |
|
0 |
2 |
|
|
|
|
|
||||||
|
|
|
As of |
||||||
GBP million |
|
|
30.9.16 |
30.6.16 |
31.12.15 |
||||
|
|
|
|
|
|
||||
Balance sheet¹ |
|
|
|
|
|
||||
Receivables from securities financing transactions² |
|
|
9,844 |
7,111 |
6,020 |
||||
Trading portfolio assets |
|
|
5,599 |
5,486 |
3,770 |
||||
Positive replacement values |
|
|
21,137 |
23,367 |
17,668 |
||||
Cash collateral receivables on derivative instruments |
|
|
5,739 |
6,907 |
6,027 |
||||
Financial assets designated at fair value |
|
|
4,119 |
3,993 |
666 |
||||
Other assets |
|
|
2,273 |
3,360 |
5,290 |
||||
Total assets² |
|
|
48,712 |
50,223 |
39,442 |
||||
Due to banks |
|
|
3,626 |
5,110 |
2,309 |
||||
Payables from securities financing transactions² |
|
|
6,301 |
4,398 |
4,025 |
||||
Trading portfolio liabilities |
|
|
6,420 |
5,057 |
4,787 |
||||
Negative replacement values |
|
|
21,895 |
24,590 |
18,040 |
||||
Cash collateral payables on derivative instruments |
|
|
5,553 |
6,149 |
5,966 |
||||
Other liabilities |
|
|
1,848 |
1,781 |
1,273 |
||||
Total liabilities² |
|
|
45,643 |
47,085 |
36,400 |
||||
Total equity |
|
|
3,069 |
3,137 |
3,042 |
||||
1 The selected financial information of UBS Limited is prepared in accordance with International Financial Reporting Standards (IFRS), as endorsed by the European Union (EU), and is stated in British pounds (GBP), the functional currency of the entity, but does not represent interim financial statements. 2 In the third quarter of 2016, prior-period information was corrected for receivables and payables from securities financing transactions. As a result, total assets as of 30 June 2016 and 31 December 2015 decreased by GBP 1,014 million and GBP 664 million, respectively, with equal decreases in total liabilities. |
|||||||||
3
Disclosures in this section are required Pillar 3 disclosures in accordance with EBA guidelines and include information on UBS Limited's eligible regulatory capital and capital requirements, as well as on capital and leverage ratios. There is no disclosure requirement for the liquidity coverage ratio for UBS Limited as of 30 September 2016.
The capital adequacy framework consists of three pillars, which each focus on a different aspect of capital adequacy. Pillar 1 provides a framework for measuring minimum capital requirements for credit, market and operational risk exposures of banks. Pillar 2 addresses the principles of the supervisory review process, emphasising the need for a qualitative approach to supervising banks. Pillar 3 aims to encourage market discipline by requiring banks to publish a range of disclosures, mainly on risk and capital.
Eligible regulatory capital represents the total amount of regulatory capital which is available to cover all of the risks identified under CRD IV. The table below represents the regulatory capital of UBS Limited split by class of capital, including required regulatory adjustments made.
Eligible regulatory capital |
||||
GBP million |
|
30.9.16 |
30.6.16 |
31.12.15 |
CET 1 before adjustments |
|
2,798 |
2,801 |
2,807 |
Regulatory adjustments |
|
(263) |
(263) |
(239) |
CET 1 capital |
|
2,535 |
2,538 |
2,568 |
Additional tier 1 capital |
|
235 |
235 |
235 |
Tier 1 capital |
|
2,770 |
2,773 |
2,803 |
Tier 2 capital |
|
682 |
660 |
587 |
Total eligible capital |
|
3,452 |
3,433 |
3,390 |
The capital requirements shown below represent the Pillar 1 capital requirements. UBS Limited has to hold capital in excess of this total amount to cover Pillar 2 obligations and the relevant regulatory buffers.
Pillar 1 capital requirements |
|||||||||
|
|
30.9.16 |
|
30.6.16 |
|
31.12.15 |
|||
GBP million |
|
RWA |
Capital |
|
RWA |
Capital |
|
RWA |
Capital |
Credit, counterparty credit risk |
|
|
|
|
|
|
|
|
|
Central governments and central banks |
|
3 |
0 |
|
2 |
0 |
|
2 |
0 |
Regional governments and local authorities |
|
45 |
4 |
|
47 |
4 |
|
29 |
2 |
Public sector entities |
|
44 |
4 |
|
43 |
3 |
|
31 |
2 |
Multilateral development banks |
|
0 |
0 |
|
0 |
0 |
|
0 |
0 |
Institutions |
|
1,928 |
154 |
|
2,217 |
177 |
|
1,999 |
161 |
Corporates |
|
4,102 |
328 |
|
4,242 |
340 |
|
4,419 |
354 |
Items associated with particularly high risk |
|
0 |
0 |
|
1 |
0 |
|
0 |
0 |
Securitisation positions |
|
7 |
1 |
|
12 |
1 |
|
39 |
3 |
Equity |
|
2 |
0 |
|
2 |
0 |
|
2 |
0 |
Other Items |
|
103 |
8 |
|
113 |
9 |
|
142 |
11 |
Total credit, counterparty credit risk |
|
6,234 |
499 |
|
6,679 |
534 |
|
6,663 |
533 |
Risk exposure amount for contribution to the default funds of central counterparties |
|
482 |
39 |
|
684 |
55 |
|
634 |
51 |
Settlement risk |
|
16 |
1 |
|
52 |
4 |
|
66 |
5 |
Position, foreign exchange and commodities risk |
|
2,619 |
210 |
|
2,300 |
185 |
|
2,227 |
178 |
Operational risk |
|
1,381 |
110 |
|
1,381 |
110 |
|
1,325 |
106 |
Credit valuation adjustment exposure |
|
1,342 |
107 |
|
1,358 |
109 |
|
1,402 |
112 |
Large Exposures charge |
|
|
|
|
318 |
25 |
|
|
|
Total risk-weighted assets and capital required |
|
12,074 |
966 |
|
12,772 |
1,022 |
|
12,317 |
985 |
4
The table below provides the key capital ratios of UBS Limited. They represent the capital position of UBS Limited based upon the Pillar 1 requirements defined by CRD IV.
Capital ratios |
||||
In % |
|
30.9.16 |
30.6.16 |
31.12.15 |
CET1 capital ratio |
|
21.0 |
19.9 |
20.8 |
Tier 1 capital ratio |
|
22.9 |
21.7 |
22.8 |
Total capital ratio |
|
28.6 |
26.9 |
27.5 |
The table below sets out the required disclosure for the leverage ratio of UBS Limited. The leverage ratio is calculated in accordance with the regulations defined by CRD IV.
Leverage ratio |
||||
GBP million, except where indicated |
|
30.9.16 |
30.6.16 |
31.12.15 |
Tier 1 capital |
|
2,770 |
2,773 |
2,803 |
Leverage ratio denominator |
|
42,644 |
42,744 |
37,807 |
Leverage ratio % |
|
6.5 |
6.5 |
7.4 |
5
Notice to investors | This document and the information contained herein are provided solely for information purposes, and are not to be construed as solicitation of an offer to buy or sell any securities or other financial instruments in Switzerland, the United States or any other jurisdiction. No investment decision relating to securities of or relating to UBS Group AG, UBS AG, UBS Limited or their affiliates should be made on the basis of this document. Refer to UBS’s third quarter 2016 report and its Annual Report 2015 for additional information. These reports are available at www.ubs.com/investors.
Rounding | Numbers presented throughout this document may not add up precisely to the totals provided in the tables and text. Percentages, percent changes and absolute variances are calculated on the basis of rounded figures displayed in the tables and text and may not precisely reflect the percentages, percent changes and absolute variances that would be derived based on figures that are not rounded.
Tables | Within tables, blank fields generally indicate that the field is not applicable or not meaningful, or that information is not available as of the relevant date or for the relevant period. Zero values generally indicate that the respective figure is zero on an actual or rounded basis. Percentage changes are presented as a mathematical calculation of the change between periods.
6
Selected financial information¹ |
|
|
|
|
|
|
For the quarter ended |
|
Year-to-date |
USD million |
|
30.9.16 |
|
30.9.16 |
|
|
|
|
|
Income statement |
|
|
|
|
Net interest income (including credit loss expense / recovery) |
|
298 |
|
945 |
Net fee and commission income |
|
1,992 |
|
5,913 |
Net trading income |
|
157 |
|
376 |
Other income |
|
179 |
|
416 |
Total operating income |
|
2,626 |
|
7,650 |
Personnel expenses |
|
1,728 |
|
5,228 |
General and administrative expenses |
|
886 |
|
2,123 |
Other operating expenses |
|
63 |
|
184 |
Total operating expenses |
|
2,677 |
|
7,535 |
Operating profit / (loss) before tax |
|
(51) |
|
115 |
Tax expense / (benefit) |
|
(1,319) |
|
(1,304) |
Net profit / (loss) |
|
1,268 |
|
1,419 |
|
|
|
|
|
|
|
As of |
||
USD million |
|
30.9.16 |
|
31.12.15 |
|
|
|
|
|
Balance sheet |
|
|
|
|
Cash and balances with central banks |
|
9,413 |
|
6,713 |
Due from banks |
|
6,103 |
|
13,883 |
Receivables from securities financing transactions |
|
48,518 |
|
59,446 |
Financials assets at fair value |
|
18,540 |
|
8,218 |
Loans and other receivables from customers |
|
51,919 |
|
49,562 |
Securities available for sale |
|
6,226 |
|
5,162 |
Goodwill and other intangible assets |
|
6,265 |
|
6,310 |
Deferred tax assets |
|
8,960 |
|
7,689 |
Other assets |
|
7,077 |
|
6,094 |
Total assets |
|
163,021 |
|
163,077 |
Due to banks |
|
38,950 |
|
23,262 |
Payables from securities financing transactions |
|
23,828 |
|
35,359 |
Deposits and payables to customers |
|
65,109 |
|
71,482 |
Financial liabilities at fair value |
|
5,872 |
|
4,370 |
Other liabilities |
|
6,665 |
|
9,430 |
Total liabilities |
|
140,425 |
|
143,903 |
Total equity |
|
22,596 |
|
19,174 |
1 The UBS Americas Holding LLC consolidated selected financial information is prepared in accordance with accounting principles generally accepted in the US (US GAAP), but does not represent interim financial statements under US GAAP. |
A summary of the regulatory capital components and ratios for UBS Americas Holding LLC will be available as of 10 November 2016 under "Disclosure for legal entities" at www.ubs.com/investors.
2
Notice to investors | This document and the information contained herein are provided solely for information purposes, and are not to be construed as solicitation of an offer to buy or sell any securities or other financial instruments in Switzerland, the United States or any other jurisdiction. No investment decision relating to securities of or relating to UBS Group AG, UBS AG or their affiliates should be made on the basis of this document. Refer to UBS’s third quarter 2016 report and its Annual Report 2015 for additional information. These reports are available at www.ubs.com/investors.
Rounding | Numbers presented throughout this document may not add up precisely to the totals provided in the tables and text. Percentages, percent changes and absolute variances are calculated on the basis of rounded figures displayed in the tables and text and may not precisely reflect the percentages, percent changes and absolute variances that would be derived based on figures that are not rounded.
Tables | Within tables, blank fields generally indicate that the field is not applicable or not meaningful, or that information is not available as of the relevant date or for the relevant period. Zero values generally indicate that the respective figure is zero on an actual or rounded basis. Percentage changes are presented as a mathematical calculation of the change between periods.
3
This Form 6-K is hereby incorporated by reference into (1) each of the registration statements of UBS AG on Form F-3 (Registration Number 333-204908) and of UBS Group AG on Form S-8 (Registration Numbers 333-200634; 333-200635; 333-200641; and 333-200665), and into each prospectus outstanding under any of the foregoing registration statements, (2) any outstanding offering circular or similar document issued or authorized by UBS AG that incorporates by reference any Form 6-K’s of UBS 111572), the AG that are incorporated into its registration statements filed with the SEC, and (3) the base prospectus of Corporate Asset Backed Corporation (“CABCO”) dated June 23, 2004 (Registration Number 333- Form 8-K of CABCO filed and dated June 23, 2004 (SEC File Number 001-13444), and the Prospectus Supplements relating to the CABCO Series 2004-101 Trust dated May 10, 2004 and May 17, 2004 (Registration Number 033-91744 and 033-91744-05).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
UBS Group AG
By: _/s/ Todd Tuckner___________ _
Name: Todd Tuckner
Title: Group Controller and
Chief Accounting Officer
By: _/s/ David Kelly_____________
Name: David Kelly
Title: Managing Director
UBS AG
By: _/s/ Todd Tuckner___________ _
Name: Todd Tuckner
Title: Group Controller and
Chief Accounting Officer
By: _/s/ David Kelly_____________
Name: David Kelly
Title: Managing Director
Date: October 28, 2016